Literature DB >> 1662660

Ovarian fibrothecoma: sonographic and histologic findings.

M Conte1, L Guariglia, P Benedetti Panici, G Scambia, C Rabitti, A Capelli, S Mancuso.   

Abstract

The sonographic and histologic findings observed in 11 cases of ovarian fibrothecoma were compared, and an attempt was made to find a correlation between each histologic type of the tumor (pure thecoma, predominantly fibrous fibrothecoma, mixed fibrothecoma) and its sonographic appearance. The presence of a homogeneous echogenic pattern, with marked posterior acoustic shadowing, in the absence of any calcification, was highly suggestive of a predominantly fibrous ovarian fibrothecoma; the presence of a diffusely hypoechoic ovarian mass, with no posterior echo enhancement, was strikingly correlated with pure thecomas; mixed fibrothecomas were characterized by the presence of an echogenic pattern with no posterior acoustic shadowing. Sonographic findings, even though nonspecific, can provide the clinician with useful information which permits to detect these rare neoplasms preoperatively.

Entities:  

Mesh:

Year:  1991        PMID: 1662660     DOI: 10.1159/000292992

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  Immunohistochemical localization patterns for vimentin and other intermediate filaments in calcified ovarian fibrothecoma.

Authors:  Eric Scott Sills; Terrence B Doan; R James Mock; George R Dixson; Michael B Rohlfing
Journal:  Diagn Pathol       Date:  2006-09-11       Impact factor: 2.644

2.  Laparoscopic surgical management and clinical characteristics of ovarian fibromas.

Authors:  Chang Eop Son; Joong Sub Choi; Jung Hun Lee; Seung Wook Jeon; Jin Hwa Hong; Jong Woon Bae
Journal:  JSLS       Date:  2011 Jan-Mar       Impact factor: 2.172

3.  Ovarian thecoma-fibroma groups: clinical and sonographic features with pathological comparison.

Authors:  Hui Chen; Yan Liu; Li-Fei Shen; Mei-Jiao Jiang; Zhi-Fang Yang; Guo-Ping Fang
Journal:  J Ovarian Res       Date:  2016-11-22       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.